Dashboard
Manage Tickers

BIVI


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biovie-announces-fda-authorization-of-investigational-new-drug-application-for-phase-2-trial-to-evaluate-bezisterim-in-long-covid-authorization-puts-co-on-track-to-receive-additional-126m-grand-from-us-dod-and-initiate-phase-2-trial
BioVie Announces FDA Authorization Of Inve...
09/03/2024 12:01:39

biovie-announces-data-from-oral-bezisterim-presentation-at-aging-research-and-drug-discovery-meeting-says-bezisterim-appears-to-possess-broad-homeostatic-properties-relevant-to-inflammation-and-human-disorders-related-to-aging
BioVie Announces Data From Oral Bezisterim...
08/27/2024 12:46:58

biovie-presents-overview-of-bezisterim-clinical-data-on-longevity-at-11th-aging-research-and-drug-discovery-meeting
BioVie Presents Overview Of Bezisterim Cli...
08/13/2024 12:21:17

BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug ther...

biovie-achieved-alignment-with-the-fda-on-its-upcoming-sunrise-pd-trial-in-parkinsons-disease-as-a-result-the-company-is-conducting-trial-start-up-activities-with-a-view-to-initiate-patient-screening-in-q4-2024
BioVie Achieved Alignment With The FDA On ...
08/08/2024 10:09:32

SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson's d...

biovie-announces-1-for-10-reverse-stock-split-now-effective
BioVie Announces 1-for-10 Reverse Stock Sp...
08/06/2024 21:26:17

Common Stock Trading On Split-Adjusted Basis Under Symbol "BIVI" With New CUSIP 09074F405

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
08/06/2024 12:55:06

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
08/05/2024 23:50:04

thinkequity-initiates-coverage-on-biovie-with-buy-rating-announces-price-target-of-3
ThinkEquity Initiates Coverage On BioVie w...
07/01/2024 10:52:55

ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.

biovie-presents-protocol-design-of-upcoming-sunrise-pd-phase-2-trial-of-bezisterim-in-patients-with-early-parkinsons-disease-at-atmrd-2024
BioVie Presents Protocol Design Of Upcomin...
06/25/2024 12:11:51

SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson's d...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/10/2024 20:31:12

biovie-forms-advisory-board-to-provide-strategic-guidance-for-bezisterim-in-long-covid
BioVie Forms Advisory Board To Provide Str...
06/04/2024 12:13:13

biovies-bezisterim-full-dataset-from-phase-2a-trial-in-parkinsons-disease-patients-experienced-significant-improvements-in-both-non-motor-symptoms-and-motor-control-while-placebo-treated-patients-worsened
BioVie's Bezisterim Full Dataset From Phas...
05/22/2024 12:14:37

Full Dataset from Phase 2a trial in Parkinson's Disease suggest patients treated with bezisterim experienced significant im...

biovie-awarded-up-to-131m-in-funding-from-us-department-of-defense-to-evaluate-bezisterim-ne3107-for-long-covid-the-study-is-expected-to-start-in-early-2025
BioVie Awarded Up To $13.1M In Funding Fro...
04/29/2024 12:04:11

biovie-presents-data-showing-potential-for-bezisterim-to-reduce-inflammation-and-restore-homeostasis-in-a-manner-correlated-with-alzheimers-disease-and-biomarker-endpoints
BioVie Presents Data Showing Potential For...
04/25/2024 12:29:21

"Bezisterim" has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeos...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/24/2024 12:06:37

biovie-to-present-data-showing-how-ne3107-potentially-restores-homeostasis-via-specific-genes-associated-with-dementia-metabolism-and-inflammation
BioVie To Present Data Showing How NE3107 ...
04/18/2024 12:09:02

BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug the...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/15/2024 20:31:28

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/01/2024 20:31:02

biovie-says-recently-completed-funding-round-provides-opportunity-to-further-its-clinical-priorities-in-parkinsons-disease-alzheimers-disease-and-ascitesliver-disease-the-company-continues-to-explore-longevity-and-aging-in-conjunction-with-partners
BioVie Says Recently Completed Funding Rou...
03/11/2024 12:02:23

crude-oil-down-over-1-quoin-pharmaceuticals-shares-spike-higher
Crude Oil Down Over 1%; Quoin Pharmaceutic...
03/04/2024 19:34:26

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION